In the spirit of Mutually Benefiting, Beijing Tide Pharmaceutical Co., Ltd. (Tide) is open for all-dimensional collaborations and exchanges with pharmaceutical companies, universities, and research institutes in China and abroad. Tide is actively seeking domestic and international partnerships in the form of technology acquisition or joint development with focus on novel drugs, formulations with special features such as targeted delivery or controlled release, and biologics. The sought therapeutic areas include cardiovascular, anti-inflammatory and analgesic, and anti-cancer drugs. In addition, Tide is also seeking partnerships to jointly introduce existing products to international markets.

 

With sales force covering the whole country, solid R&D foundation, state-of-the-art production facilities and quality control system, as well as its experiences in successful long-term collaboration with research institutions at home and abroad, multinational pharmaceutical companies in Europe, US and Japan, Tide stands ready for future collaboration.

 

Major forms of collaboration:

l   Technology acquisition 

l   Joint development

l   Other forms

1
1
2
2
3
3
4
4
5
5
6
6
7
7

R&D